Home Healthcare Pharmaceuticals Anti-Rheumatics Market

Anti-Rheumatics Market Size, Share & Trends Analysis Report By Drug Class (Disease Modifying Anti-Rheumatic Drugs, Nonsteroidal Anti-inflammatory Drugs, Corticosteroids, Uric Acid Drugs, Others), By Type (Prescription-Based Drugs, Over-the-Counter Drugs) and By Country (U.S., Canada) Forecasts, 2026-2034

Last Updated: July 09, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Anti-Rheumatics Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. Disease Modifying Anti-Rheumatic Drugs
    2. Nonsteroidal Anti-inflammatory Drugs
    3. Corticosteroids
    4. Uric Acid Drugs
    5. Others
  2. Anti-Rheumatics Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Prescription-Based Drugs
    2. Over-the-Counter Drugs
  3. Regional Anti-Rheumatics Market
    1. North America
      1. North America Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      2. North America Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
      3. U.S.
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      4. Canada
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
    2. Europe
      1. Europe Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      2. Europe Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
      3. U.K.
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      4. Germany
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      5. France
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      6. Spain
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      7. Italy
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      8. Russia
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      9. Nordic
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      10. Benelux
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      11. Rest of Europe
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
    3. APAC
      1. APAC Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      2. APAC Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
      3. China
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      4. Korea
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      5. Japan
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      6. India
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      7. Australia
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      8. Singapore
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      9. Taiwan
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      10. South East Asia
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      11. Rest of Asia-Pacific
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
    4. Middle East and Africa
      1. Middle East and Africa Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      2. Middle East and Africa Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
      3. UAE
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      4. Turkey
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      5. Saudi Arabia
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      6. South Africa
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      7. Egypt
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      8. Nigeria
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      9. Rest of MEA
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
    5. LATAM
      1. LATAM Anti-Rheumatics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      2. LATAM Anti-Rheumatics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
      3. Brazil
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      4. Mexico
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      5. Argentina
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      6. Chile
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      7. Colombia
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
      8. Rest of LATAM
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
        6. Prescription-Based Drugs
        7. Over-the-Counter Drugs
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.